Vumerity®
Quick Facts
Immune system modulator that dampens inflammatory response and may have antioxidant properties.
Capsule taken orally
Twice daily after a first week titration
Relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting MS, and active secondary-progressive MS
Potential Benefit:
Vumerity® data is based on trials of its bioequivalnet, dimethyl fumarate, compared to placebo over 2 years:
- 44-53% fewers relapses
- 21-38% less likely to experience disability progression
Over 2 years MRI showed:
- 74-90% fewers Gd+ lesions
- 71- 85% fewer T2 lesions
- 57- 72% fewer T1 lesions
Common Potential Side Effects
Flushing, stomach problems, redness, itching, rash
Prescription Assistance:
For assistance finding additional resources that might help cover the costs of your prescription, contact MSAA.
DRUGMAKER
Biogen
HOW Vumerity® WORKS
The disease modifying therapy Vumerity® is an immune system modulator thought to reduce inflammation. Vumerity® may also have antioxidant properties that help prevent damage to key parts of the central nervous system (CNS) such as the brain and spinal cord. Vumerity® is in the same class of MS therapy as Tecfidera, but causes fewer gastrointestinal (GI) side effects.
FDA-Approved
FDA approved in 2019 to treat relapsing forms of MS, including clinically isolated syndrome, relapsing-remitting disease, and active secondary-progressive disease, in adults.
Potential Side Effects
Flushing and stomach problems are common, especially at the start of therapy, and may decrease over time; redness, itching, rash, or diarrhea may also occur. Vumerity® is in the same class of MS therapy as Tecfidera®, but is believed to cause fewer gastrointestinal (GI) side effects. Other side effects include herpes zoster infections (shingles), central nervous system infections, decreases in your white blood cell count, and liver problems. A possible serious side effect is progressive multifocal leukoencephalopathy (PML), a rare brain infection that usually leads to death or severe disability over a period of weeks or months.
OTHER KEY INFORMATION
Your healthcare provider will likely recommend blood tests after the first 6 months of treatment and every 6 -12 months after that.
Testing completed prior to starting Vumerity® includes:
- Complete Blood Count (including lymphocytes)
- Liver Function Tests
Regular testing completed after starting Vumerity® includes:
- Complete Blood Count (including lymphocytes)
- Liver Function Tests
When taking Vumerity, please note there is a titration period (starting at a smaller dose and increasing over successive weeks).